Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO for hematopoietic reconstruction after umbilical cord blood transplantation
ChiCTR-IPR-16009357Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Oct 2016
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of recombinant human thrombopoietin in hematopoietic malignancies and Post-umbilical cord blood transplantation status (Post-UCBT) (3 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: Platelet implantation time. Started Oct 2016; status: recruiting.
02
Drugs
recombinant human thrombopoietin
03
Conditions
hematopoietic malignanciesPost-umbilical cord blood transplantation status (Post-UCBT)
Beyond the preview
Go deeper on ChiCTR-IPR-16009357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009357.